Golden Throat Holdings Group Company Limited Logo

Golden Throat Holdings Group Company Limited

6896.HK

(3.5)
Stock Price

3,13 HKD

12.23% ROA

23.36% ROE

8.26x PER

Market Cap.

2.321.783.845,42 HKD

17.71% DER

10.5% Yield

29.89% NPM

Golden Throat Holdings Group Company Limited Stock Analysis

Golden Throat Holdings Group Company Limited Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Golden Throat Holdings Group Company Limited Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (19.37%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

3 DER

The stock has a minimal amount of debt (18%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Dividend

Shareholders can rely on the company's remarkable dividend history, consistently paying dividends for the past five years, demonstrating a steadfast dedication to rewarding investors.

5 PBV

The stock's PBV ratio (1.26x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

6 Revenue Growth

This company's revenue has shown remarkable growth over the past three years, making it an excellent choice for seeking a consistently prosperous investment.

7 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

9 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last three years, showcasing a commitment to providing higher returns.

10 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (11), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

11 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

Golden Throat Holdings Group Company Limited Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Golden Throat Holdings Group Company Limited Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Golden Throat Holdings Group Company Limited Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Golden Throat Holdings Group Company Limited Revenue
Year Revenue Growth
2014 606.801.000
2015 706.922.000 14.16%
2016 768.171.000 7.97%
2017 624.084.000 -23.09%
2018 694.194.000 10.1%
2019 797.129.000 12.91%
2020 646.941.000 -23.22%
2021 820.543.000 21.16%
2022 992.014.000 17.29%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Golden Throat Holdings Group Company Limited Research and Development Expenses
Year Research and Development Expenses Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Golden Throat Holdings Group Company Limited General and Administrative Expenses
Year General and Administrative Expenses Growth
2014 59.101.000
2015 78.364.000 24.58%
2016 69.190.000 -13.26%
2017 56.225.000 -23.06%
2018 65.877.000 14.65%
2019 77.540.000 15.04%
2020 83.526.000 7.17%
2021 103.178.000 19.05%
2022 78.557.000 -31.34%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Golden Throat Holdings Group Company Limited EBITDA
Year EBITDA Growth
2014 177.553.000
2015 217.646.000 18.42%
2016 188.055.000 -15.74%
2017 105.181.000 -78.79%
2018 157.518.000 33.23%
2019 239.240.000 34.16%
2020 200.705.000 -19.2%
2021 278.526.000 27.94%
2022 422.740.000 34.11%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Golden Throat Holdings Group Company Limited Gross Profit
Year Gross Profit Growth
2014 429.908.000
2015 522.104.000 17.66%
2016 554.940.000 5.92%
2017 435.589.000 -27.4%
2018 516.515.000 15.67%
2019 598.456.000 13.69%
2020 475.643.000 -25.82%
2021 577.736.000 17.67%
2022 720.920.000 19.86%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Golden Throat Holdings Group Company Limited Net Profit
Year Net Profit Growth
2014 121.893.000
2015 154.618.000 21.17%
2016 102.912.000 -50.24%
2017 61.380.000 -67.66%
2018 102.186.000 39.93%
2019 167.613.000 39.03%
2020 154.052.000 -8.8%
2021 187.643.000 17.9%
2022 281.218.000 33.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Golden Throat Holdings Group Company Limited Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2014 0
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Golden Throat Holdings Group Company Limited Free Cashflow
Year Free Cashflow Growth
2014 169.208.000
2015 48.205.000 -251.02%
2016 4.381.000 -1000.32%
2017 -7.706.000 156.85%
2018 67.442.000 111.43%
2019 21.560.500 -212.8%
2020 83.798.000 74.27%
2021 108.326.000 22.64%
2022 255.299.000 57.57%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Golden Throat Holdings Group Company Limited Operating Cashflow
Year Operating Cashflow Growth
2014 173.256.000
2015 51.235.000 -238.16%
2016 13.259.000 -286.42%
2017 79.902.000 83.41%
2018 189.208.000 57.77%
2019 53.897.500 -251.05%
2020 167.746.000 67.87%
2021 164.889.000 -1.73%
2022 271.146.000 39.19%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Golden Throat Holdings Group Company Limited Capital Expenditure
Year Capital Expenditure Growth
2014 4.048.000
2015 3.030.000 -33.6%
2016 8.878.000 65.87%
2017 87.608.000 89.87%
2018 121.766.000 28.05%
2019 32.337.000 -276.55%
2020 83.948.000 61.48%
2021 56.563.000 -48.42%
2022 15.847.000 -256.93%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Golden Throat Holdings Group Company Limited Equity
Year Equity Growth
2014 91.352.000
2015 968.445.000 90.57%
2016 986.757.000 1.86%
2017 944.453.000 -4.48%
2018 1.057.212.000 10.67%
2019 1.154.129.000 8.4%
2020 1.220.342.000 5.43%
2021 1.365.143.000 10.61%
2022 1.539.111.000 11.3%
2023 1.428.873.000 -7.72%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Golden Throat Holdings Group Company Limited Assets
Year Assets Growth
2014 568.026.000
2015 1.301.440.000 56.35%
2016 1.432.412.000 9.14%
2017 1.362.145.000 -5.16%
2018 1.485.959.000 8.33%
2019 1.626.953.000 8.67%
2020 1.685.088.000 3.45%
2021 1.953.179.000 13.73%
2022 2.299.290.000 15.05%
2023 1.956.178.000 -17.54%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Golden Throat Holdings Group Company Limited Liabilities
Year Liabilities Growth
2014 476.674.000
2015 332.995.000 -43.15%
2016 445.655.000 25.28%
2017 417.692.000 -6.69%
2018 428.747.000 2.58%
2019 472.824.000 9.32%
2020 464.746.000 -1.74%
2021 588.036.000 20.97%
2022 760.179.000 22.65%
2023 527.305.000 -44.16%

Golden Throat Holdings Group Company Limited Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
1.34
Net Income per Share
0.38
Price to Earning Ratio
8.26x
Price To Sales Ratio
2.34x
POCF Ratio
8.56
PFCF Ratio
9.09
Price to Book Ratio
1.51
EV to Sales
1.71
EV Over EBITDA
4.02
EV to Operating CashFlow
6.27
EV to FreeCashFlow
6.65
Earnings Yield
0.12
FreeCashFlow Yield
0.11
Market Cap
2,32 Bil.
Enterprise Value
1,70 Bil.
Graham Number
4.22
Graham NetNet
0.25

Income Statement Metrics

Net Income per Share
0.38
Income Quality
0.72
ROE
0.19
Return On Assets
0.18
Return On Capital Employed
0.31
Net Income per EBT
0.76
EBT Per Ebit
1.02
Ebit per Revenue
0.38
Effective Tax Rate
0.24

Margins

Sales, General, & Administrative to Revenue
0.08
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.74
Operating Profit Margin
0.38
Pretax Profit Margin
0.39
Net Profit Margin
0.3

Dividends

Dividend Yield
0.1
Dividend Yield %
10.5
Payout Ratio
0.4
Dividend Per Share
0.36

Operating Metrics

Operating Cashflow per Share
0.37
Free CashFlow per Share
0.35
Capex to Operating CashFlow
-0.06
Capex to Revenue
-0.02
Capex to Depreciation
-0.41
Return on Invested Capital
0.16
Return on Tangible Assets
0.12
Days Sales Outstanding
0
Days Payables Outstanding
34.08
Days of Inventory on Hand
62.34
Receivables Turnover
0
Payables Turnover
10.71
Inventory Turnover
5.86
Capex per Share
-0.02

Balance Sheet

Cash per Share
1,25
Book Value per Share
2,08
Tangible Book Value per Share
2.08
Shareholders Equity per Share
2.08
Interest Debt per Share
0.38
Debt to Equity
0.18
Debt to Assets
0.12
Net Debt to EBITDA
-1.47
Current Ratio
2.44
Tangible Asset Value
1,54 Bil.
Net Current Asset Value
1,03 Bil.
Invested Capital
0.18
Working Capital
1,06 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,02 Bil.
Average Inventory
55630500
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Golden Throat Holdings Group Company Limited Dividends
Year Dividends Growth
2016 0
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Golden Throat Holdings Group Company Limited Profile

About Golden Throat Holdings Group Company Limited

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People's Republic of China. It offers Golden Throat lozenges over-the-counter medicine to relive symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat lozenge series products that include Dule lozenges and sugar-free Dule lozenges in various flavors, such as orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn; Yinxingye tablet, which is designed to facilitate blood circulation, remove blood stasis, and dredge energy channels; and herbal vegetable beverages for soothing voice and relieving sore throats. The company also exports its products to the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and Africa. Golden Throat Holdings Group Company Limited was founded in 1956 and is headquartered in Liuzhou, the People's Republic of China.

CEO
Mr. Yong Zeng
Employee
860
Address
No.28 Yuejin Road
Liuzhou,

Golden Throat Holdings Group Company Limited Executives & BODs

Golden Throat Holdings Group Company Limited Executives & BODs
# Name Age
1 Mr. Jianping Huang
Deputy GM, President of Labour Union & Executive Director
70
2 Mr. Kexiong Zeng
Deputy GM & Executive Director
70
3 Mr. Jinqiang He
Deputy GM & Executive Director
70
4 Mr. Dong Wu
Assistant to General Manager
70
5 Ms. Pui Shan Lee
Company Secretary
70
6 Mr. Qiang Cheng
Chief Financial Officer & Assistant to GM
70
7 Ms. Qing Li
Deputy Head of Manufacturing Technology Department & Assistant to GM
70
8 Mr. Yong Zeng
Vice Chairman & GM
70

Golden Throat Holdings Group Company Limited Competitors